Spencer Nam

Spencer is a Managing Partner at KSV Global where he focuses on novel technologies and therapeutics in healthcare. Prior to joining KSV Global, Spencer was a senior research fellow at the Christensen Institute for Disruptive Innovation where he researched disruptive innovation models in healthcare.

Prior to Christensen Institute, Spencer spent 10 years as a licensed securities analyst on Wall Street where he had research coverage on medical devices, diagnostics and life science tools companies.

Before Wall Street, Spencer was a consultant at Bain & Company where he advised senior management teams of Fortune 500 companies. Spencer holds AB in Mathematics from Harvard College and an MBA from Harvard Business School.